BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11306570)

  • 1. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.
    van Kempen LC; Nelissen JM; Degen WG; Torensma R; Weidle UH; Bloemers HP; Figdor CG; Swart GW
    J Biol Chem; 2001 Jul; 276(28):25783-90. PubMed ID: 11306570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
    Swart GW
    Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
    Piazza T; Cha E; Bongarzone I; Canevari S; Bolognesi A; Polito L; Bargellesi A; Sassi F; Ferrini S; Fabbi M
    J Cell Sci; 2005 Apr; 118(Pt 7):1515-25. PubMed ID: 15769845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.
    Gilsanz A; Sánchez-Martín L; Gutiérrez-López MD; Ovalle S; Machado-Pineda Y; Reyes R; Swart GW; Figdor CG; Lafuente EM; Cabañas C
    Cell Mol Life Sci; 2013 Feb; 70(3):475-93. PubMed ID: 23052204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
    Ikeda K; Quertermous T
    J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALCAM/CD166: cancer-related issues.
    Weidle UH; Eggle D; Klostermann S; Swart GW
    Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
    van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
    J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
    Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
    Fernández MM; Ferragut F; Cárdenas Delgado VM; Bracalente C; Bravo AI; Cagnoni AJ; Nuñez M; Morosi LG; Quinta HR; Espelt MV; Troncoso MF; Wolfenstein-Todel C; Mariño KV; Malchiodi EL; Rabinovich GA; Elola MT
    Biochim Biophys Acta; 2016 Oct; 1860(10):2255-68. PubMed ID: 27130882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
    Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
    J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration.
    Masedunskas A; King JA; Tan F; Cochran R; Stevens T; Sviridov D; Ofori-Acquah SF
    FEBS Lett; 2006 May; 580(11):2637-45. PubMed ID: 16650408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
    Bowen MA; Aruffo AA; Bajorath J
    Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.
    von Lersner A; Droesen L; Zijlstra A
    Clin Exp Metastasis; 2019 Apr; 36(2):87-95. PubMed ID: 30778704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
    Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
    J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166).
    Fujiwara H; Tatsumi K; Kosaka K; Sato Y; Higuchi T; Yoshioka S; Maeda M; Ueda M; Fujii S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3437-43. PubMed ID: 12843199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
    Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
    Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
    Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
    Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of activated leukocyte cell adhesion molecule-mediated homotypic cell adhesion through the actin cytoskeleton.
    Nelissen JM; Peters IM; de Grooth BG; van Kooyk Y; Figdor CG
    Mol Biol Cell; 2000 Jun; 11(6):2057-68. PubMed ID: 10848629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.